top of page

.png)

At CPHI & Pharmapack, we were proud to take part in one of the most influential global gatherings for pharmaceutical innovation. Our presence at the event allowed us to connect with industry leaders, showcase our commitment to advanced healthcare solutions, and explore new opportunities for collaboration. These photos capture the energy, conversations, and meaningful moments that inspired us throughout the experience.
![]() | ![]() | ![]() | ![]() |
|---|---|---|---|
![]() | ![]() | ![]() | ![]() |

In the Dominican Republic, ClorNasal continues to grow through strong partnerships and an active presence in the community. From pharmacy visits to key events and press briefings, these moments reflect our impact—and signal what’s ahead, as more of our products will soon arrive in the country.
![]() | ![]() | ![]() | ![]() |
|---|---|---|---|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() |
Panama ClorNasal
We officially launched ClorNasal in Panama through an event that showcased the product from its creation and history to the key reasons why it is essential in everyday life. We highlighted the importance of being present in the routine of every Panamanian, recognizing that the city’s climate makes it crucial to prepare and protect the body against environmental changes.

![]() | ![]() | ![]() | ![]() |
|---|---|---|---|
![]() | ![]() | ![]() | ![]() |
![]() |
.png)

Since its inception in 2004, the CPHI Pharma Awards have recognized innovators driving the pharmaceutical industry forward. In 2022, we proudly attended the event and were honored to be finalists in the Finished Formulation category.
![]() | ![]() | ![]() | ![]() |
|---|---|---|---|
![]() | ![]() | ![]() | ![]() |
80% of wound infections traced by DNA to bacteria in the patients' own nose
Approximately 60 million Americans suffer from allergies each year, making it the 6th leading cause of chronic illness in the country.
Intranasal corticosteroids are the most effective treatments for allergic rhinitis, providing relief for up to 80% of patients.
bottom of page






































